Who is sponsoring NCT02939157?

NCT02939157 is sponsored by Umeå University.

What drugs are being tested in NCT02939157?

Interventions in NCT02939157: Cardiac diagnostic ultrasound.

What condition does NCT02939157 study?

NCT02939157 studies Heart Failure, Congestive, Cardiac Failure.

Is NCT02939157 still recruiting?

NCT02939157 is currently completed. Last updated 29 November 2018.

Last reviewed 2018-11-29 · How we verify

NCT02939157: POCUS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pocket-sized Ultrasound for Point-of-care Diagnosis of Heart Failure

Completed Last updated 29 November 2018

What this trial tests

trial testing Cardiac diagnostic ultrasound in Heart Failure, Congestive in 158 participants. Completed in 30 December 2017.

Timeline

12 December 2016

Primary endpoint
15 June 2017

30 December 2017

Quick facts

Lead sponsor	Umeå University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	158
Start date	12 December 2016
Primary completion	15 June 2017
Estimated completion	30 December 2017

Drugs / interventions tested

Cardiac diagnostic ultrasound

Conditions studied

Heart Failure, Congestive — all drugs for Heart Failure, Congestive →
Cardiac Failure — all drugs for Cardiac Failure →

Sponsor

Umeå University

Who can join

20 and older, any sex, with Heart Failure, Congestive or Cardiac Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of pocket sized ultrasound (Vscan GE Healthcare) for diagnosing heart failure in primary care patients, with a comprehensive cardiac ultrasound examination (Siemens Acusan P10) performed at a specialized the eco.lab, as reference.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Hand-held cardiac ultrasound examinations performed in primary care patients by nonexperts to identify reduced ejection fraction.
Nilsson G, Söderström L, Alverlind K, Samuelsson E, et al · · 2019 · cited 13× · PMID 31345207 · DOI 10.1186/s12909-019-1713-9

Verify or expand the search:

Other recruiting trials for Heart Failure, Congestive

Currently open trials in the same condition.

NCT06689215 — Comparison of Noninvasive vs. Invasive Hemodynamic Measurements · active not recruiting
NCT06218199 — Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts · Phase 4 · recruiting

Other Umeå University trials

Trials by the same sponsor.

NCT07407946 — Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion · NA · recruiting
NCT07346820 — VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation · not yet recruiting
NCT07417358 — Single-Stapled Technique for Colorectal Anastomosis · recruiting
NCT07316426 — Preoptimisation in Ventral Hernia Surgery · NA · recruiting
NCT07170722 — Sub-threshold DRG Stimulation vs Sham in Established Responders · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02939157 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Umeå University
Last refreshed: 29 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02939157.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing